TCM
WVE icon

Tang Capital Management’s Wave Life Sciences WVE Stock Holding History

Tang Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49M Hold
600,000
– – 0.16% 37
2026
Q1 		$4.35M Hold
600,000
– – 0.22% 39
2025
Q4 		$10.2M Buy
+600,000
New +$6.1M 0.5% 40

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Tang Capital Management's WVE Position: Q2 2026 in Review

Tang Capital Management held its Wave Life Sciences (WVE) position steady in Q2 2026 at 600,000 shares worth $3.49M. The position accounts for 0.16% of the portfolio, ranked #37.

Tang Capital Management first reported a position in WVE in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.2M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Tang Capital Management held 600,000 shares of Wave Life Sciences worth $3.49M as of Q2 2026.
  • Tang Capital Management left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up 0.16% of Tang Capital Management's portfolio in Q2 2026, its #37 holding.
  • Tang Capital Management first reported a position in Wave Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Tang Capital Management's Wave Life Sciences position peaked at $10.2M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.